E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 8/7/2009 in the Prospect News PIPE Daily.

New Issue: Lifevantage settles second tranche of $2.4 million common stock sale

By Devika Patel

Knoxville, Tenn., Aug. 7 - Lifevantage Corp. completed a $904,287 second tranche of a $2.4 million private placement of stock on Aug. 5, according to an 8-K filed Friday with the Securities and Exchange Commission. The company raised $1.5 million in the first tranche on June 30.

The company sold 4,285,714 common shares at $0.35 each along with warrants for 857,142 shares in the first tranche. It sold 2,583,668 shares and warrants for 516,724 shares in this tranche.

The warrants will be exercisable at $0.50 for three years.

Greenwood Village, Colo.-based Lifevantage specializes in health products.

Issuer:Lifevantage Corp.
Issue:Common stock
Amount:$2,404,284
Shares:6,869,382
Price:$0.35
Warrants:For 1,373,866 shares
Warrant expiration:Three years
Warrant strike price:$0.50
Settlement date:June 30 (for $1.5 million), Aug. 5 (for $904,287)
Stock symbol:OTCBB: LFVN
Stock price:$0.67 at close June 30
Market capitalization:$22.9 million

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.